MS MuSings

Monthly Online Magazine

by and for those with MS,

Multiple Sclerosis

April 2007

 

 

Homepage

Tables of Contents

Features

Real Life Stories

Poetry

Fiction

FYI

Theme

Tips & Tricks

Our Pride and Joy!

Other Monthly

Durable Goods Exchange

Related Links

Who's in Issue91

 Awards, 91

Ahead to May

Guestbook

Archives

Gallery

Please Visit

The World of MS  MuSings

 

 

 

FYI

From Stuart

(Varying Topics of Interest) For Caregivers/

Therapies/ Hobbies / Balos / etc

 

 

 Stu's Views and M.S. Related  News:::
Click HERE to view MS articles of interest
Disclaimer: This website and blog is solely my own personal views and research.
I am not an expert in the field of MS nor a medical practitioner
opt-out at any time by simply replying with your request 
==========================================================
"We must become the change, we want to see in the world"- Mahatma Gandhi
 

The diagnosis of multiple sclerosis (MS) causes a substantial burden on both patients and those who care for them. Individuals affected by MS need information about the disease and its treatment, as well as physical, financial, and emotional support as they struggle to maintain their quality of life under very demanding circumstances.


March 30, '07: Treating MS Symptoms and Side Effects of Immunomodulatory Therapy


Botulinum toxin type A (BoNT-A) and cannabis-based medication represent advances in therapy for MS symptoms such as spasticity and bladder dysfunction. In addition, the psychostimulant modafinil appears to improve cognitive function and fatigue when added to interferon (IFN) therapy in the treatment of MS. Several studies presented at recent congresses evaluated these new treatment approaches. Another study evaluated a method to diminish injection-site reactions.

Cancer, Alzheimer's and Tumor-Related Therapeutics Now Able to be Tracked in Hours

Case Center for Imaging Research One of a Handful in the Nation


New Oral Agents for Multiple Sclerosis, Including Novartis/Mitsubishi Pharma's Novel Drug, Will Capture 25% of Market Share by 2020

» Read More


March 29, '07: Hobbies:


A Rare MS-Like Disease
Like MS, Balo's concentric sclerosis (BCS) is a disease featured by extensive damage to myelin, a protective, fatty sheath that covers nerve fibers in the central nervous system. But unlike MS, Balo's concentric sclerosis is very rare and the odds of survival are grim. Reportedly, people diagnosed with this disease can die within weeks to months.2

Deadline Nears for DoD Funding Bill
Contact Your Representative During the Recess

More Info

 

Interest continues to grow in providing $15 million to the Congressionally Directed Medical Research Program for multiple sclerosis (MS) research within the annual Department of Defense appropriations bill.  The upcoming Congressional recess will be a key time to emphasize this issue.  There are several ways you can reach your Representative back in their home districts April 2-14.  You can:

  • Call your Representative's district office.
  • Make an appointment to visit with your Representative in the district.
  • Attend a community or town hall meeting.  Call the district office for a schedule.

To find your Representative’s district contact information, visit:  www.house.gov.

Ask them to sign on to the Dear Colleague letter being circulated in the House of Representatives by Congressmen Russ Carnahan (D-MO) and Rick Renzi (R-AZ).  The deadline to sign on recently has been extended until  April 20.

Consider the following information when speaking with your Representative:

MS is a chronic, often disabling disease of the central nervous system and is generally diagnosed between the ages of 20 and 50, the prime of life. There is no cure for MS and symptoms are unpredictable. Current medical treatments are not effective for many people and cannot be tolerated by many others.

Unfortunately, the National Institutes of Health, currently the primary source of funding for MS research, is reducing its investment over the next couple years. Supplementing current MS research with additional resources from the DoD could help further investigate the causes of such neurological disorders, explore additional treatments, and help find a cure. Preliminary evidence suggests that Gulf War veterans could have an increased risk of developing MS.

  • A recent study in the Annals of Neurology, for example, identified 5,345 cases of MS among U.S. veterans that were deemed "service-connected." The number of service-connected cases was a significant increase from previous studies. 

  • An epidemiologic study found an unexpected, two-fold increase in MS between 1993 and 2000 in Kuwait, which suggests a potential environmental trigger for MS. 

  • A 2004 report from a study group commissioned by the VA suggests more research must be done on the potential link between MS and combat service. 

  • The Congressionally-mandated Research Advisory Committee on Gulf War Veterans' Illnesses (RAC) found that evidence supports a probable link between exposures to neurotoxins and the development of neurological disorders.

The DoD has an obligation to fund research into MS related to Gulf War service.  This research would not only benefit our Gulf War veterans, but could help move us closer to a world free of MS for all those living with the disease.

Be an MS Activist.  Join the Movement at www.nationalMSsociety.org/advocacy

To keep future MS activism messages out of your junk folder, add the following address to your contacts or safe sender list:  MSActionNetwork@nmss.org


 
top of page